| Identification | Back Directory | [Name]
Bunamiodyl | [CAS]
1233-53-0 | [Synonyms]
buniodyl
Bunamiodyl
Bunamiodilo
Bunamiodylum
Bunamijodylum
Bunamiodyl [inn:ban]
Bunamiodilo [inn-spanish]
1923-76-8 (Hydrochloride salt)
3-(3-Butylamido-2,4,6-triiodphenyl)-2-ethylacrylsaeure
2-(3-Butyramido-3,4,6-triiodophenylmethylene)butyric acid
2-[[2,4,6-Triiodo-3-[(1-oxobutyl)amino]phenyl]methylene]butanoic acid
Butanoic acid, 2-[[2,4,6-triiodo-3-[(1-oxobutyl)amino]phenyl]methylene]- | [Molecular Formula]
C15H16I3NO3 | [MDL Number]
MFCD00068997 | [MOL File]
1233-53-0.mol | [Molecular Weight]
639.01 |
| Hazard Information | Back Directory | [Definition]
ChEBI: Bunamiodyl is a member of cinnamic acids. | [Brand name]
Bunaiod;Orabilex;Orabilix. | [World Health Organization (WHO)]
Bunamiodyl, an orally administered radio-opaque medium, was
introduced in 1958 for use in the examination of the biliary tract. By 1964 its use
had been associated with cases of renal failure, in some cases fatal, which resulted
in its withdrawal by the United States Food and Drug Administration. Buniamiodyl
was withdrawn worldwide by the manufacturer in 1984. |
|
| Company Name: |
Leancare Ltd.
|
| Tel: |
+33 962096793 |
| Website: |
www.leancare.co.uk |
|